OBJECTIVES: To characterize the mechanism of cefoxitin resistance in clinical isolate Escherichia coli N99-0001. METHODS: Plasmid analysis, PCR for beta-lactamases, and sequencing of the ampC genes was carried out. An RT-PCR method was developed to determine relative ampC expression. RESULTS: Analysis of the ampC promoter region of E. coli N99-0001 revealed a T-->A mutation at -32, a C-->A mutation at -11, an insertion of a T between -20 and -21, and a 28 bp deletion including the entire attenuator. RT-PCR showed that ampC was expressed 140-fold higher in E. coli N99-0001 than in E. coli ATCC 25922. CONCLUSIONS: Cefoxitin resistance in E. coli N99-0001 was due to overexpression of ampC caused by an increase in promoter strength.
OBJECTIVES: To characterize the mechanism of cefoxitin resistance in clinical isolate Escherichia coli N99-0001. METHODS: Plasmid analysis, PCR for beta-lactamases, and sequencing of the ampC genes was carried out. An RT-PCR method was developed to determine relative ampC expression. RESULTS: Analysis of the ampC promoter region of E. coli N99-0001 revealed a T-->A mutation at -32, a C-->A mutation at -11, an insertion of a T between -20 and -21, and a 28 bp deletion including the entire attenuator. RT-PCR showed that ampC was expressed 140-fold higher in E. coli N99-0001 than in E. coli ATCC 25922. CONCLUSIONS:Cefoxitin resistance in E. coli N99-0001 was due to overexpression of ampC caused by an increase in promoter strength.
Authors: Silke Polsfuss; Guido V Bloemberg; Jacqueline Giger; Vera Meyer; Erik C Böttger; Michael Hombach Journal: J Clin Microbiol Date: 2011-06-01 Impact factor: 5.948
Authors: M J Gude; C Seral; Y Sáenz; M González-Domínguez; C Torres; F J Castillo Journal: Eur J Clin Microbiol Infect Dis Date: 2012-01-26 Impact factor: 3.267
Authors: S Peter-Getzlaff; S Polsfuss; M Poledica; M Hombach; J Giger; E C Böttger; R Zbinden; G V Bloemberg Journal: J Clin Microbiol Date: 2011-06-08 Impact factor: 5.948
Authors: Adam Belley; Michael D Huband; Kelley A Fedler; Amy A Watters; Robert K Flamm; Stuart Shapiro; Philipp Knechtle Journal: J Clin Microbiol Date: 2019-07-26 Impact factor: 5.948
Authors: L F Mataseje; N Neumann; B Crago; P Baudry; G G Zhanel; M Louie; M R Mulvey Journal: Antimicrob Agents Chemother Date: 2009-04-27 Impact factor: 5.191
Authors: Tomasz A Leski; Gary J Vora; Brian R Barrows; Guillermo Pimentel; Brent L House; Matilda Nicklasson; Momtaz Wasfy; Mohamed Abdel-Maksoud; Chris Rowe Taitt Journal: PLoS One Date: 2013-07-25 Impact factor: 3.240